UK markets open in 26 minutes

Compass Therapeutics, Inc. (CMPX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.6900+0.0400 (+2.42%)
At close: 04:00PM EST
1.6900 0.00 (0.00%)
After hours: 04:03PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 214.18M
Enterprise value 52.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.34
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.21

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 3-62.69%
S&P500 52-week change 314.90%
52-week high 35.6500
52-week low 31.3900
50-day moving average 31.8012
200-day moving average 32.6893

Share statistics

Avg vol (3-month) 3308.62k
Avg vol (10-day) 3438.69k
Shares outstanding 5127.49M
Implied shares outstanding 6128.25M
Float 891.95M
% held by insiders 115.69%
% held by institutions 164.96%
Shares short (14 Nov 2023) 42.97M
Short ratio (14 Nov 2023) 49.8
Short % of float (14 Nov 2023) 43.25%
Short % of shares outstanding (14 Nov 2023) 42.33%
Shares short (prior month 12 Oct 2023) 43.27M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-20.08%
Return on equity (ttm)-29.46%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -47.12M
Net income avi to common (ttm)-40.67M
Diluted EPS (ttm)-0.3300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)163.7M
Total cash per share (mrq)1.28
Total debt (mrq)2.04M
Total debt/equity (mrq)1.28%
Current ratio (mrq)18.26
Book value per share (mrq)1.26

Cash flow statement

Operating cash flow (ttm)-38.91M
Levered free cash flow (ttm)-24.02M